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NMR spectroscopyAtaxin-3, which is encoded by a gene that has been associated with Machado–Joseph disease, con-
tains a catalytic N-terminal Josephin domain with deubiquitinase activity. Here, we show that the
Josephin domain of ataxin 3 catalyzes endo-type cleavage of Lys48-linked polyubiquitin. Further-
more, NMR data obtained following site-speciﬁc paramagnetic spin labeling of Lys48-linked di-ubiq-
uitin revealed that both ubiquitin units interact with the Josephin domain, with the C-terminal
Gly76 of the proximal unit being situated in the vicinity of the catalytic triad of Josephin domain.
Our results help to elucidate how the substrate is recognized by the Josephin domain and properly
positioned for an endo-type deubiquitination reaction.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction DNA repair, inﬂammatory response and cell survival [1,2]. TheUbiquitination is a reversible protein modiﬁcation that regu-
lates various biological processes including cell-cycle progression,covalent attachment of ubiquitin (Ub) to target proteins is cata-
lyzed by the sequential action of the Ub-activating enzyme E1,
Ub-conjugating enzyme E2, and Ub-protein ligase E3. The carboxy
terminus of Ub can also be attached to another Ub (termed the
distal and proximal Ub moieties, respectively) through all seven
lysine residues at positions 6, 11, 27, 29, 33, 48, and 63 and the
amino terminus, giving rise to various types of polyUb chains
[3,4], which act as fate determinants of ubiquitinated proteins.
The K48-linked polyUb chain (K48-Ub) serves as a signal for pro-
tein degradation by 26S proteasomes, whereas the K63-linked
polyUb chain (K63-Ub) plays a non-degradative role such as DNA
repair and transcriptional regulation.
Ubiquitination is counteracted by a group of hydrolytic
enzymes collectively termed deubiquitinases (DUBs), which
remove Ub from protein adducts [5]. DUBs are classiﬁed into zinc
metalloproteases and cysteine proteases. While the former consist
of only one family, JAB1/MPN/MOV34 (JAMM) metalloproteases,
the latter are further categorized into four families on the basis
of the structure of the catalytic domain: Ub carboxyl-terminal
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proteases (OTUs), and the Josephin domain proteases.
One of the best-studied members of the Josephin family is
ataxin-3, which possesses an N-terminal Josephin domain, two
Ub-interacting motifs (UIMs), and a polyglutamine (polyQ) tract
followed by the third UIM depending on splice variants [6,7]. This
protein is encoded by the gene responsible for spinocerebellar
ataxia type 3, also known as Machado–Joseph disease, which is
an autosomal dominant neurodegenerative disease caused by
expansion of the polyQ tract [8]. It has been reported that full-
length ataxin-3 preferentially cleaves K63-linkage, especially that
are situated in K48/K63-mixed linkage of polyUb chains with four
or more Ub moieties [7,9]. Intriguingly, the intrinsic DUB activity of
ataxin-3’s isolated Josephin domain is directed towards K48-Ub in
comparison with K63-Ub [10]. Similarly, UIM-mutated full-length
ataxin-3 showed an increased activity toward K48-Ub, suggesting
that the UIM motifs were involved in speciﬁc interaction with
K63-Ub chains [9].
To date, several 3D structures of the Josephin domain of ataxin-
3 have been determined, uncovering different conformational
states [11,12]. These data suggest that the domain is in a dynamic
equilibrium between open and closed conformations. Recently,
NMR spectroscopic data proposed the interaction mode between
the Josephin domain and K48-Ub2 with two Ub-binding sites (S1
and S2) [10,13]. Herein, the S-site numbering is based on the stan-
dard protease nomenclature; hydrolysis occurs between the distal
S1 and proximal S10 site. Crystallographic data of the Josephin
domain of ataxin-3-like protein (ATXN3L) proposed a similar inter-
action mode of JosephinUb (S1) complex compared to the NMR
data [14].
It has been shown that ubiquitination of ataxin-3 directly
enhances its DUB activity in mammalian cells [15] and Drosophila
[16]. The primary ubiquitination site was identiﬁed at Lys117,
which is located near the catalytic triad of the Josephin domain.
Although the up-regulation mechanism by this ubiquitination
remains to be elucidated, the Ub moiety at Lys117 would clearly
hamper accommodation of the proximal Ub unit at the S1 site
based on the previously proposed 3D models of JosephinUb
(S1) complex [10,13].
In Ub chain disassembly, DUB-catalyzed cleavage can take place
from the end (exo-type) or within a chain (endo-type). USP14, one
of the proteasome-associated DUBs, exhibited an exo-type activity
toward K48-Ub from the distal end [17]. By contrast, the USP
domain of cylindromatosis (CYLD) and several OTU DUBs such as
OTUD2 have endo-type DUB activities toward Lys63- and Lys11-
linkages of heterotypic tetra- and pentaUb chains, respectively
[18,19]. However, such well-deﬁned information for DUB speciﬁc-
ities has been very limited. It has also reported that ataxin-3 pos-
sesses an endo-type DUB activity with heterotypic polyUb
containing K63 linkage ﬂanked by K48 linkages [9]. However, it
remains unknown whether this enzyme have endo-type DUB
activity toward homotypic polyUb chains.
In this study, we revisit the interaction mode between the Jose-
phin domain of ataxin-3 and K48-Ub2. We demonstrate that the
ataxin-3 Josephin domain possess an endo-DUB activity against
K48-Ub and propose a distinct interaction model based on NMR
data obtained using site-speciﬁc spin labeling.
2. Materials and methods
2.1. Protein expression and puriﬁcation of full-length and Josephin
domain of ataxin-3
The full-length human ataxin-3 was expressed in Escherichia
coli BL21(DE3) CodonPlus (Agilent Technologies) using pHis8 vec-
tor and puriﬁed by Ni2+-immobilized column. The cDNA fragmentencoding the Josephin domain (residues 1–171) was inserted into
the pGEX-6P-1 plasmid vector (GE Healthcare) with an N-terminal
GST tag. For the expression of the Josephin domain, E. coli BL21
(DE3) CodonPlus transformed with the plasmid was cultured in
LB or M9 minimal medium. The GST-fused protein was puriﬁed
from the cell lysate on a Glutathione Sepharose 4B column (GE
Healthcare). The protein was further puriﬁed using a Superdex
75 (10/30) gel ﬁltration column (GE Healthcare). For the NMR
analyses, stable isotope-labeled proteins were obtained by culti-
vating E. coli in M9 synthetic medium containing 15NH4Cl and
15NH4Cl/13C-glucose as the sole source of nitrogen/carbon, respec-
tively. Stable isotope labeling of protein at selected amino acid
residues were performed as previously described [20].
2.2. Deubiquitinase assay
Enzymatic synthesis of K48-Ub with hexahistidine (His6) tag at
the C-terminus of the proximal unit was performed using the
protocol described in the literature [21]. Brieﬂy, 0.2 mM Ub and
0.2 mM His6-tagged Ub were mixed in 50 mM Tris–HCl (pH 8.0)
and incubated at 310 K for 6 h in the presence of 1 lM E1, 40 lM
E2–25 K, 1 mM dithiothreitol (DTT), 5 mM MgCl2, 10 mM ATP,
0.6 U/ml creatine phosphokinase, 0.6 U/ml pyrophosphatase,
and 10 mM creatine phosphate. After the reaction, Ub chains with
the His6 tag were puriﬁed from the reaction mixture by 100 ll
of Ni Sepharose High Performance column (GE Healthcare).
Deubiquitination assay using the K48-Ub substrates bound to the
Ni2+-immobilized beads (5 ll) was performed in a ﬁnal volume
of 100 ll in 20 mM Tris–HCl buffer (pH 8.0) containing 1 mM
DTT at 310 K for 12 h. After the reaction, 10 ll of the resin-
unbound fraction was collected, boiled in SDS-containing sample
buffer, and subjected to SDS–PAGE and immunoblotted with a
Ub-speciﬁc antibody (Santa Cruz Biotechnology). For the deubiqui-
tination assay, 1 lM Josephin domain, 1 lM ataxin-3, and 2 mg/ml
26S proteasome were used.
2.3. Synthesis of K48-Ub2 and the subunit-speciﬁc isotope and spin
labeling
For NMR analysis of the 15N-labeled Josephin domain, non-
labeled K48-Ub2 were synthesized in vitro as described [22].
Subunit-speciﬁc isotope labeling of K48-Ub2 was also achieved
by using 15N-labeled Ub derivatives [D77 (proximal, S1) and
K48R (distal, S2)]. In this paper, the Ub unit that carries the free
Gly76 residues is deﬁned as the proximal S1 Ub (which can be
isopeptide-linked to a substrate through its C-terminus), whereas
the distal S2 unit is that which carries the free Lys48 side
chain.
For subunit-speciﬁc spin labeling, the C-terminal Gly76 of the
proximal Ub or Lys48 of the distal Ub were substituted with a cys-
teine residue, which was disulﬁde-linked to a paramagnetic spin
label [MTSL, (1-oxy-2,2,5,5-tetramethyl-D-pyrroline-3-methyl)-
methanethiosulfonate, Toronto Research Chemicals]. Immediately
before the spin labeling, DTT was removed from the buffer using
desalting column (PD-10, GE Healthcare). The composition of the
buffer used for equilibrium and spin labeling was 50 mM Tris–
HCl (pH 8.0), 100 mM NaCl. The sulfhydryl group at the mutated
site was then modiﬁed with a 10-M excess of the spin label at
310 K for 6 h. After removal of unreacted spin label reagent using
PD-10 column, the spin-labeled protein was further puriﬁed using
a Superdex 75 (10/30) gel ﬁltration column.
2.4. NMR measurements and spectral analysis
NMR samples were prepared in 90% H2O/10% D2O (v/v), 10 mM
sodium phosphate buffer at pH 7.0 and experiments were
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and DMX-500 spectrometers equipped with 5-mm triple-
resonance probes. Backbone assignments were obtained with 3D
HNCA, HN(CO)CA, HNCO, HN(CA)CO, HNCACB, and CBCA(CO)NH
experiments. Side chain assignments were derived from 3D
HCCH-COSY, HCCH-TOCSY, and 15N-edited TOCSY experiments.
Hydrogen bond restraints were obtained from 2D 1H–15N HSQC
spectra by hydrogen–deuterium exchange reaction in 99.9% D2O.
NOE restraints were obtained from 2D 1H–1H NOESY, 3D 15N-edi-
ted NOESY, and 13C-edited NOESY spectra. The time domain data
were processed with NMRPipe software package [23]. Semiauto-
matic assignment of the resonance peaks from each amino acid
residue was carried out using the Olivia software (http://
fermi.pharm.hokudai.ac.jp/olivia/). For 3D structure calculation,
the backbone dihedral angle restrains for w and u were created
by TALOS [24]. NOE assignments and structure calculation were
conducted using CYANA2.1 [25]. A total 100 structures were calcu-
lated and the 10 lowest target function structures were selected to
present the 3D structure model of the ataxin-3 Josephin domain.
The stereochemical qualities of the calculated structures were
assessed using PROCHECK-NMR [26]. Chemical shift perturbation
and paramagnetic relaxation enhancement (PRE) data were
collected based on 1H–15N-HSQC spectral observation at a proton
frequency of 500 MHz. The data are displayed for each residues
according to the equation (0.04DdN2 + DdH2)1/2, where DdN and DdH
represent the change in nitrogen and proton chemical shifts.
2.5. Computation modeling of Josephin domain/K48-Ub2 complex
The proposed model of the Josephin domain/K48-Ub2 complex
was constructed using the protein–protein docking and molecular
dynamics simulation procedure as follows. The NMR structures of
the Josephin domain determined in this study (2DOS) and the
atomic coordinates of K48-Ub2 coordinates adopted from the PDB
entry of its complex with the C-terminal UBA domain of human
HR23A (1ZO6) were used as starting models. Both PDB entries
were deposited as an ensemble of multiple superimposed models.
Using clustering analysis of multiple models, we selected model 8
and 2 for the Josephin domain and K48-Ub2, respectively, as repre-
sentative for the initial coordinate.
We used ZDOCK version 3.0.2 [27] to generate 2000 candidate
conformation for each protein–protein docking step. Since several
PDB entries of K48-Ub2 exhibit considerable conformational differ-
ences depending on its binding partners, ensemble-based docking
was adopted for accommodating protein ﬂexibility of K48-Ub2 dur-
ing docking process. We prepared a structurally diverse set of K48-
Ub2 constituted from 35 conformers by scanning the w angle of
Leu73 andu angle of Gly75 of distal-ubiquitin, which were derived
from the initial coordinates using Coordinate Scan program in
MacroModel (Schrödinger, LLC).
During the protein docking procedure, NMR chemical shift per-
turbation data were utilized as constraints so as to exclude resi-
dues with little or no chemical shift changes (less than 0.07 ppm)
upon complex formation from the protein docking interface. This
generated to 70,000 (35*2000) complex models as candidates,
which were modiﬁed with disulﬁde-linked MTSL groups and then
evaluated based on distance constraints provided by the PRE data.
The lowest-penalty model was subjected to 50 ns molecular
dynamics-based energy minimization using program Desmond
version 3.4.0.1 [28], giving rise to the ﬁnal 3D model. The
OPLS2005 force ﬁeld was used for the simulations. Initial model
structures were placed into a TIP3P water molecules solvated with
0.15 M NaCl. After minimization and relaxation of model, the
production MD phase was performed for 50 ns in the isothermal-
isobaric (NPT) ensemble at 300 K and 1 bar using the Langevin
dynamics. Long-range electrostatic interactions were computedusing the Smooth Particle Mesh Ewald method. All system setups
were performed using Maestro (Schrödinger, LLC).
3. Results and discussion
3.1. The Josephin domain of ataxin-3 shows endo-type deubiquitinase
activity
It has been shown that the isolated Josephin domain of ataxin-3
preferentially cleaves K48-Ub as compared with K63-Ub [10] in
contrast to the ﬁnding that the full-length ataxin-3 preferentially
cleaves K63-linked isopeptide bond in a heterotypic Ub4 substrate
(UbK48–UbK63–UbK48–Ub) [9]. To further examine the DUB activity
of the Josephin domain, we designed a novel DUB assay using
homotypic K48-Ub substrates bound to Ni2+-immobilized beads
connected via the C-terminal His6-tag of proximal Ub (Fig. 1A). This
assay system allows us to discriminate between exo- or endo-pro-
teolyzed products because the cleavage products containing the
proximal Ub remain bound to resin, while the remaining products
are released. Fig. 1B showed that the resin-unbound fraction of the
ataxin-3 digestion products were composed of Ub2–5 species but
did not contain monoUb in contrast to the deubiquitination reac-
tion catalyzed by 26S proteasome, which released only monoUb
into the unbound fractions. These data demonstrate that the
ataxin-3 has an endo-type DUB activity against K48-Ub (Fig. 1B).
We conﬁrmed that the Josephin domain alone also exhibited the
endo-DUB activity, which was completely lost in the inactive
mutant in which catalytic Cys14 residue was substituted with ala-
nine (Fig. 1C). These data demonstrate that the Josephin domain of
ataxin-3 possesses endo-type DUB activities against K48-Ub.
3.2. Comparison of the solution structures of the Josephin domain of
ataxin-3
Two groups have independently reported the solution struc-
tures of the Josephin domain solved by NMR spectroscopy
[11,12]. According to those structural analyses, the Josephin
domain belongs to papain-like cysteine protease family, which
includes papain, cathepsin, staphopain, and other Ub hydrolases.
It should be noted that signiﬁcant structural difference of the
extended helical arm (a2–a3) was observed between the two
reported structures despite their striking overall similarity. We
also determined the solution structure of the Josephin domain by
NMR spectroscopy with sufﬁcient statistics (Table 1 and Supple-
mentary Fig. S1) and found that our structure exhibited a ‘half-
closed’ conformation of the extended helical arm as compared with
previous structures (Fig. 2). The variable conformations were
thought to be concerned with the recognition mode of its speciﬁc
substrates. Beside the intrinsic conformational ﬂexibility of the
extended helical arm, these structural variations are probably
due to the different experimental conditions, i.e., 298 K, pH 6.4 or
pH 6.5 [11,12] or 303 K, pH 7.0 (this study). In the apo forms,
‘closed’ (PDB code: 2AGA) and ‘half open’ (PDB code: 1YZB) confor-
mations were observed [11,12]. In contrast, ‘open’ (PDB code: 2JRI)
conformation was observed in the K48-Ub2-bound model [13].
Collectively, our current structure together with previous data
[11–13] demonstrates that the Josephin domain of ataxin-3 has a
highly ﬂexible extended helical arm (a2–a3) exhibiting dynamic
equilibrium between open and closed states that are potentially
important for substrate recognition. This observation is well
consistent with previous NMR relaxation data [12].
3.3. Interaction of the Josephin domain with K48-Ub2
To investigate the interaction mode of the Josephin domain
with K48-Ub, we compared the 1H and 15N chemical shifts of the
Fig. 1. Ataxin-3 exhibited endo-deubiquitinase activities against Lys48-linked polyubiquitin. (A) Experimental scheme of DUB activity assay. (B) DUB activities of full-length
ataxin-3 and 26S proteasome. (C) DUB activities of the WT and mutated Josephin domains. These assays identiﬁed distal Ub-containing Ub chains that were released from the
resin by the treatment with 1 lM Josephin domain, 1 lM ataxin-3, or 2 mg/ml 26S proteasome.
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and absence of K48-Ub2. Upon addition of K48-Ub2, spectral
changes were extensively observed for the Josephin domain sur-
face, suggesting the existence of multiple Ub-binding sites
(Fig. 3A) essentially consistent with the previous reports [10,13].
One major area is in proximity with the active site includingGlu7, Gln16, Ser29, Ser34, Asp71, and Glu118, and the other is
located at the opposite site including Phe28, Lys85, Val86, and
Trp87 (Fig. 3B). In addition, this backside interaction area corre-
sponds with the previously reported interaction surface of Ub-like
domain of human HR23B [12]. Consistently, mutations of the inter-
acting residues including Phe28, Ser29, Val86, and Trp87 affected
Table 1
Structural data of the Josephin domain of ataxin-3.
Restraints used in the structure calculation
Number of distance restraints 4075
Short-range (residue i to i + j, j<=1) 3075
Medium-range (residue i to i + j, j = 2–4) 410
Long-range (residue i to i + j, j > 4) 561
Number of hydrogen bonds 83
Number of torsion angle restraints
u 102
w 102
Geometric statistics
R.M.S.D from the mean structurea (Å)
Backbone atoms of secondary structure elementsb 0.51 ± 0.11
Heavy atoms of secondary structure elementsb 1.14 ± 0.18
Ramachandran analysis (%)
Most favored regions 87.4
Additional allowed regions 11.6
Generously allowed regions 0.1
Disallowed regions 1.0
a Mean coordinates were obtained by averaging coordinates of the 10 calculated
structures.
b Residues 15–22, 78–85, 90–93, 111–116, 119–126, 129–134, 141–143, 145–
158 and 161–166.
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of V86A was signiﬁcantly decreased as compared with that of wild
type, and the F28A mutant did not show the detectable activity,
indicating importance of these amino acid residues for the DUB
activity.
Next, we conducted NMR interaction analyses using (distal or
proximal) subunit-speciﬁc 15N-labeled K48-Ub2 to identify the
binding site on the K48-Ub2 (Fig. 3C and D). The chemical shift per-
turbation data indicated that both of the Ub units are involved in
the interaction with the Josephin domain through its canonical
hydrophobic ‘Ile44 surface’, a common binding site for various
Ub binding domains [29].
3.4. Hypothetical model of the interaction between the Josephin
domain and K48-Ub2
We made site-speciﬁc spin labeled proteins as sources of
long-range distance information to determine the orientation of180o 
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2 
3 
180o 180o 
Fig. 2. Comparison of the solution structures of the Josephin domain of ataxin-3: (A) ‘h
1YZB); (D) ‘open’ (yellow, 2JRI); (E) their superimposed models. The upper and lower str
open’ structures are derived from the uncomplexed forms. These two NMR data were coll
‘open’ structure is adopted from the docking model with K48-Ub2 [13]. In contrast, our N
‘half close’ conformation.K48-Ub2 with respect to the Josephin domain. The C-terminal
Gly76 of the proximal Ub or Lys48 of the distal Ub was substituted
with a cysteine residue, which was covalently linked to paramag-
netic spin label MTSL. Upon complex formation of the K48-Ub2
analog spin-labeled at the C-terminus of the proximal Ub, the
HSQC peaks originating from the active site residues of the
Josephin domain including Gly11, Cys14, Ser34, Glu118, and
His119 exhibited remarkable line broadening due to PRE
(Fig. 4A). This observation indicated that the C-terminal Gly76 of
the proximal Ub was situated around the active site of the
Josephin domain. As for K48-Ub2 analog with spin-label at the
position 48 of distal Ub, essentially only one peak originating from
Leu93 locating at the backside surface of the Josephin domain
showed signiﬁcant line broadening (Fig. 4B), indicating its close
proximity with Lys48 of distal Ub. This observation was obviously
inconsistent with the previously proposed model of the complex
between the Josephin domain and K48-Ub2, which was made
based on the NMR spectral data observed primarily for the
Josephin domain interacting with monoUb [10,13].
Hence, using these newly obtained NMR data as constraints, we
performed a protein–protein docking and subsequent molecular
dynamics simulation. Namely, our docking model was made based
not only on the NMR chemical shift perturbation observed for both
proteins but also on the PRE data obtained using site-speciﬁc para-
magnetic spin labeling of K48-Ub2 (Fig. 5). The new model exhib-
ited critical differences from the previously proposed model
(Fig. 6). Both models commonly share the distal Ub-binding site
on the Josephine domain, which corresponds with the previously
identiﬁed interaction surface of Ub-like domain of human HR23B
[12], while the proximal Ub-binding sites are completely different
between the two models. Nicastro et al. reported intermolecular
NOEs between Gln78 and Trp120 of the Josephin domain and
Leu8 and Arg74 of the monoUb, respectively [13]. However, our
docking model is not compatible with the NOE observation
(Fig. 5). We speculate that the discrepancy was due to the differ-
ences in experimental design for obtaining docking constraints.
According to the conﬁguration of the complex, the proximal and
distal Ub units could be accommodated at S1 and S2 sites, respec-
tively, on the Josephin domain surface, illustrating a substrate
interaction mode of the endo-type DUB reaction (Fig. 7). Similarly,D E 
180o 180o 
alf close’ (pink, 2DOS, this study); (B) ‘closed’ (cyan, 2AGA); (C) ‘half open’ (green,
uctures are related by a rotation of 180 around a vertical axis. The ‘closed’ and ‘half
ected under the almost identical conditions, i.e., 298 K, pH 6.4 or pH 6.5 [11,12]. The
MR data was collected under a different condition, i.e., 303 K, pH 7.0, and revealed
Fig. 3. The Josephin domain of ataxin-3 interacts with canonical hydrophobic ‘Ile44 surfaces’ of Lys48-linked di-ubiquitin through its extensive surface area. (A) NMR
chemical shift perturbation data for the Josephin domain (0.5 mM) upon binding to K48-Ub2 (0.5 mM). Orange bars indicate residues whose NMR peaks became undetectable
due to extreme broadening. (B) Mapping of the perturbed residues of the Josephin domain upon binding to K48-Ub2. Red gradient indicates the strength of the perturbation.
Residues the peaks of which became undetectable due to signal broadening are shown in magenta. The active-site residues are labeled with red characters. (C) NMR chemical
shift perturbation data for subunit-speciﬁcally 15N-labeled K48-Ub2 (0.5 mM) observed upon binding of the Josephin domain (0.5 mM): left (distal unit), and right (proximal
unit). (D) Mapping of the perturbed residues of the K48-Ub2 upon binding to the Josephin domain. The secondary structure elements of the Josephin domain (A) and Ub (C)
are indicated above the plots.
T. Satoh et al. / FEBS Letters 588 (2014) 4422–4430 4427OTUD2 exempliﬁes an endo-type DUB possessing at least two dis-
tal Ub-binding sites [19]. By contrast, USP14, an exo-type DUB, has
exclusively one distal Ub-binding site [17]. The complex structuresof endo- or exo-DUB reactions catalyzed by these enzymes are
shown in Supplementary Fig. S2. Intriguingly, ubiquitination of
the Lys117 closely located to the catalytic triad (Cys14, His119,
Fig. 4. (A) Paramagnetic relaxation enhancement data for the Josephin domain (0.5 mM) upon binding to subunit-speciﬁcally spin-labeled K48-Ub2 (0.5 mM): upper (distal
unit), and lower (proximal unit). The data were calculated from the peak intensity ratio of the HSQC in the presence of spin-labeled K48-Ub2 before and after radical
quenching with 4 mM ascorbic acid. (B) Mapping of the residues of the Josephin domain based on the intensity ratio spin labeling data. Blue gradient indicates the strength of
the perturbation. The active-site residues are labeled with red characters.
Fig. 5. Hypothetical model of the interaction of the Josephin domain with K48-Ub2 based on the NMR chemical shift perturbation and PRE data. The surface models are
colored as in Figs. 3 and 4. The active-site residues are labeled with red characters.
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[15,16]. The ubiquitination at the Lys117 would be expected to cre-
ate steric hindrance with proximal Ub of K48-Ub2 in the previous
docking model [10,13], whereas it would not be expected to inter-
fere with the accommodation of the Ub units at S1 and S2 sites in
this new model, in which these substrate-binding sites are distalfrom the Lys117 ubiquitination site (Fig. 6). Our model implies that
the Ub moiety at this site is not directly involved in the interaction
with the substrate. The Lys117 ubiquitination may have a confor-
mational impact on the proximal active site.
In summary, using a newly designed assay system, we demon-
strate that the ataxin-3 Josephin domain has an endo-type DUB
Fig. 6. Comparison between hypothetical models of ataxin-3 Josephin domain complexed with K48-Ub2: (A), this study; (B), 2JRI [13]. The Josephin domain, proximal and
distal Ub units are colored green, yellow, and cyan, respectively. The isopeptide-bonding proximal Ub Lys48 and distal Ub Gly76, and Cys14 and Lys117 residues of the
Josephin domain are shown in spheres. The active site cysteine residues are highlighted by orange.
Fig. 7. The schematic model for endo-type DUB reaction catalyzed by the ataxin-3
Josephin domain. The proximal and distal Ub units in K48-Ub are accommodated at
S1 and S2 sites, respectively, on the Josephin domain surface, illustrating a substrate
interaction mode of the endo-type DUB reaction.
T. Satoh et al. / FEBS Letters 588 (2014) 4422–4430 4429activity against Lys48-linked polyUb. At least under these reaction
conditions we were not able to observe the exo-type reaction.
Moreover, our NMR data in conjunction with the molecular dock-
ing simulation revealed the structural basis for recognition of
Lys48-linked Ub moiety by the Josephin domain of ataxin-3,
thereby explaining its endo-type deubiquitination mechanism.PDB accession number
The atomic coordinate of the Josephin domain of human ataxin-
3 has been deposited in the Protein Data Bank (PDB). The accession
number is 2DOS.
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